PT  - JOURNAL ARTICLE
AU  - Alexander, Walter
ED  - Powell, Bayard L.
TI  - Consolidation with Arsenic Trioxide Significantly Improves Event-free Survival and Overall Survival among Patients with Newly Diagnosed Acute Promyelocytic Leukemia
DP  - 2007 Sep 01
TA  - MD Conference Express
PG  - 12--12
VI  - 7
IP  - 3
4099  - http://mdc.sagepub.com/content/7/3/12.1.short
4100  - http://mdc.sagepub.com/content/7/3/12.1.full
AB  - Arsenic trioxide is an effective and indicated agent for relapsed acute promyelocytic leukemia (APL). A study now demonstrates that arsenic trioxide has clinical benefit for patients with newly diagnosed APL. This article reports findings from the study in which arsenic trioxide was given as consolidation therapy to patients with APL who had complete remission following standard induction therapy.